Univariablea | Multivariablea | ||||
---|---|---|---|---|---|
Risk factor | Categories | Nb | Ratio of geometric means (95 % CI) [P-value] | Nb | Ratio of geometric means (95 % CI) [P-value] |
Parity | Primiparous | 93 | 0.99 (0.86, 1.14) [0.890] | 79 | 1.03 (0.89, 1.19) [0.698] |
Multiparous | 256 | 1c | 212 | 1 | |
Anti-malarial therapy | Artemisinin based | 49 | 1.28 (1.09, 1.51) [0.003] | 38 | 1.24 (1.07, 1.43) [0.003] |
Non-artemisinin based | 300 | 1 | 253 | 1 | |
Symptoms | Symptomatic | 232 | 0.89 (0.77, 1.03) [0.120] | 211 | 0.94 (0.80, 1.11) [0.459] |
Asymptomatic | 88 | 1 | 80 | 1 | |
Therapy supervision | Unsupervised | 86 | 0.83 (0.73, 0.94) [0.004] | 81 | 0.83 (0.73, 0.95) [0.006] |
Supervised | 253 | 1 | 210 | 1 | |
Intercalated P. vivax | Yes | 28 | 2.19 (1.77, 2.72) [<0.001] | 25 | 2.19 (1.76, 2.73) [<0.001] |
No | 321 | 1 | 266 | 1 | |
EGA (weeks) | 349 | 349 | 1.00 (0.99, 1.00) [0.217] | 291 | 1.00 (0.99, 1.00) [0.210] |
Parasitaemia (m/L)d | 349 | 349 | 0.98 (0.97, 1.00) [0.079] | 291 | 0.98 (0.96, 0.99) [0.014] |
Haematocrit (%) | 327 | 327 | 1.00 (0.99, 1.01) [0.618] | 291 | 1.00 (0.99, 1.01) [0.654] |